Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Soft Mist Inhalers (SMI) Market Research Report 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Soft Mist Inhalers (SMI) Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Asthma
      • 1.3.3 COPD
    • 1.4 Market Segment by Application
      • 1.4.1 Global Soft Mist Inhalers (SMI) Market Share by Application (2019-2025)
      • 1.4.2 Clinic
      • 1.4.3 Hospital
      • 1.4.4 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Soft Mist Inhalers (SMI) Production Value 2014-2025
      • 2.1.2 Global Soft Mist Inhalers (SMI) Production 2014-2025
      • 2.1.3 Global Soft Mist Inhalers (SMI) Capacity 2014-2025
      • 2.1.4 Global Soft Mist Inhalers (SMI) Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Soft Mist Inhalers (SMI) Market Size CAGR of Key Regions
      • 2.2.2 Global Soft Mist Inhalers (SMI) Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Soft Mist Inhalers (SMI) Capacity by Manufacturers
      • 3.1.2 Global Soft Mist Inhalers (SMI) Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Soft Mist Inhalers (SMI) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Soft Mist Inhalers (SMI) Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Soft Mist Inhalers (SMI) Market Concentration Ratio (CR5 and HHI)
    • 3.3 Soft Mist Inhalers (SMI) Price by Manufacturers
    • 3.4 Key Manufacturers Soft Mist Inhalers (SMI) Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Soft Mist Inhalers (SMI) Market
    • 3.6 Key Manufacturers Soft Mist Inhalers (SMI) Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Asthma Production and Production Value (2014-2019)
      • 4.1.2 COPD Production and Production Value (2014-2019)
    • 4.2 Global Soft Mist Inhalers (SMI) Production Market Share by Type
    • 4.3 Global Soft Mist Inhalers (SMI) Production Value Market Share by Type
    • 4.4 Soft Mist Inhalers (SMI) Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Soft Mist Inhalers (SMI) Consumption by Application

    6 Production by Regions

    • 6.1 Global Soft Mist Inhalers (SMI) Production (History Data) by Regions 2014-2019
    • 6.2 Global Soft Mist Inhalers (SMI) Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Soft Mist Inhalers (SMI) Production Growth Rate 2014-2019
      • 6.3.2 United States Soft Mist Inhalers (SMI) Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Soft Mist Inhalers (SMI) Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Soft Mist Inhalers (SMI) Production Growth Rate 2014-2019
      • 6.4.2 European Union Soft Mist Inhalers (SMI) Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Soft Mist Inhalers (SMI) Import & Export
    • 6.5 China
      • 6.5.1 China Soft Mist Inhalers (SMI) Production Growth Rate 2014-2019
      • 6.5.2 China Soft Mist Inhalers (SMI) Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Soft Mist Inhalers (SMI) Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Soft Mist Inhalers (SMI) Consumption by Regions

    • 7.1 Global Soft Mist Inhalers (SMI) Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Soft Mist Inhalers (SMI) Consumption by Type
      • 7.2.2 United States Soft Mist Inhalers (SMI) Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Soft Mist Inhalers (SMI) Consumption by Type
      • 7.3.2 European Union Soft Mist Inhalers (SMI) Consumption by Application
    • 7.4 China
      • 7.4.1 China Soft Mist Inhalers (SMI) Consumption by Type
      • 7.4.2 China Soft Mist Inhalers (SMI) Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Soft Mist Inhalers (SMI) Consumption by Type
      • 7.5.2 Rest of World Soft Mist Inhalers (SMI) Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 3M
      • 8.1.1 3M Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Soft Mist Inhalers (SMI)
      • 8.1.4 Soft Mist Inhalers (SMI) Product Introduction
      • 8.1.5 3M Recent Development
    • 8.2 Hovione
      • 8.2.1 Hovione Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Soft Mist Inhalers (SMI)
      • 8.2.4 Soft Mist Inhalers (SMI) Product Introduction
      • 8.2.5 Hovione Recent Development
    • 8.3 Mannkind
      • 8.3.1 Mannkind Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Soft Mist Inhalers (SMI)
      • 8.3.4 Soft Mist Inhalers (SMI) Product Introduction
      • 8.3.5 Mannkind Recent Development
    • 8.4 Meda
      • 8.4.1 Meda Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Soft Mist Inhalers (SMI)
      • 8.4.4 Soft Mist Inhalers (SMI) Product Introduction
      • 8.4.5 Meda Recent Development
    • 8.5 Novartis
      • 8.5.1 Novartis Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Soft Mist Inhalers (SMI)
      • 8.5.4 Soft Mist Inhalers (SMI) Product Introduction
      • 8.5.5 Novartis Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Soft Mist Inhalers (SMI) Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Soft Mist Inhalers (SMI) Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Soft Mist Inhalers (SMI) Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Soft Mist Inhalers (SMI) Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Soft Mist Inhalers (SMI) Production Forecast by Type
      • 9.7.2 Global Soft Mist Inhalers (SMI) Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Soft Mist Inhalers (SMI) Sales Channels
      • 10.2.2 Soft Mist Inhalers (SMI) Distributors
    • 10.3 Soft Mist Inhalers (SMI) Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      An SMI is a newer type of inhaler that provides a pre-measured amount of medicine in a slow-moving mist that helps you inhale the medicine. You put your lips on the mouthpiece while you hold the device horizontally. Be careful not to cover the air vents. This type of device actively delivers medicine in a way that doesn’t depend on how fast you breathe in the air from the inhaler.
      In 2019, the market size of Soft Mist Inhalers (SMI) is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Soft Mist Inhalers (SMI).

      This report studies the global market size of Soft Mist Inhalers (SMI), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Soft Mist Inhalers (SMI) production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      3M
      Hovione
      Mannkind
      Meda
      Novartis
      ...

      Market Segment by Product Type
      Asthma
      COPD

      Market Segment by Application
      Clinic
      Hospital
      Other

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Soft Mist Inhalers (SMI) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Soft Mist Inhalers (SMI) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Soft Mist Inhalers (SMI) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now